Literature DB >> 288318

Debrancher deficiency: neuromuscular disorder in 5 adults.

S DiMauro, G B Hartwig, A Hays, A B Eastwood, R Franco, M Olarte, M Chang, A D Roses, M Fetell, R S Schoenfeldt, L Z Stern.   

Abstract

Five patients, 4 men and 1 woman, had adult-onset and slowly progressive weakness. There was distal wasting in 2, hepatomegaly in 3, and congestive heart failure in 2. Electromyography showed a mixed pattern with abundant fibrillations. Serum creatine phosphokinase was increased 5- to 45-fold. Blood glucose failed to respond to epinephrine or glucagon, and venous lactate did not rise after ischemic exercise. Muscle biopsy showed vacuolar myopathy affecting both fiber types. By electron microscopy the vacuoles corresponded to large pools of glycogen not limited by a membrane. Glycogen concentration was 3 to 5 times normal in muscle and 7 to 21 times normal in erythrocytes. In the presence of iodine, muscle glycogen showed a spectrum characteristic of phosphorylase-limit-dextrin. Debrancher activity was measured by a spectrophotometric assay and by a radioactive reverse reaction. The activity was lacking in muscle and erythrocytes of 4 patients according to both assays; in 1 patient the reverse reaction was not impaired. Though previously reported in only 5 patients, debrancher deficiency myopathy may not be rare and should be considered in the differential diagnosis of adult-onset hereditary myopathies.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 288318     DOI: 10.1002/ana.410050504

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  25 in total

1.  Novel mutations in two Japanese cases of glycogen storage disease type IIIa and a review of the literature of the molecular basis of glycogen storage disease type III.

Authors:  T Fukuda; H Sugie; M Ito
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

Review 2.  Myopathies Related to Glycogen Metabolism Disorders.

Authors:  Mark A Tarnopolsky
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

3.  [Polyglycosan body myopathy].

Authors:  M Jeub; K Kappes-Horn; C Kornblum; D Fischer
Journal:  Nervenarzt       Date:  2006-12       Impact factor: 1.214

Review 4.  Muscle glycogenoses: an overview.

Authors:  S Di Mauro
Journal:  Acta Myol       Date:  2007-07

5.  Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId.

Authors:  H Sugie; T Fukuda; M Ito; Y Sugie; T Kojoh; I Nonaka
Journal:  J Inherit Metab Dis       Date:  2001-10       Impact factor: 4.982

6.  Cardiac involvement in glycogen storage disease type III.

Authors:  S W Moses; K L Wanderman; A Myroz; M Frydman
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183

7.  McArdle's disease: two clinical expressions in the same pedigree.

Authors:  A Papadimitriou; P Manta; R Divari; A Karabetsos; E Papadimitriou; N Bresolin
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

8.  Cardiomyopathy of glycogen storage disease type III.

Authors:  J S Carvalho; E E Matthews; J V Leonard; J Deanfield
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

9.  Myoglobinuria in carnitine palmityltransferase deficiency.

Authors:  D Rowett
Journal:  Int Urol Nephrol       Date:  1982       Impact factor: 2.370

Review 10.  Distal myopathies.

Authors:  Mazen M Dimachkie; Richard J Barohn
Journal:  Neurol Clin       Date:  2014-05-15       Impact factor: 3.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.